Patients undergoing hematopoietic stem cell transplantation. Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing hematopoietic stem cell transplantation Male and female patients over the age of 18 years Awareness of time, place and person Serum platelet levels above 50,000 Interested in participating in the study
Exclusion criteria
Exclusion criteria: Serum platelet levels less than 50,000 Infectious or bleeding diseases and wounds in the legs Deep vein thrombosis Reflective massage intolerance patient dissatisfaction to continue participation in the study Patient's death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fatigue. Timepoint: Before intervention, 7 and 10 days after intervention. Method of measurement: Brief Fatigue Inventory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: Before intervention, 7 and 10 days after intervention. Method of measurement: Spielberger anxiety inventory.;Pain. Timepoint: Before intervention, 7 and 10 days after intervention. Method of measurement: Numeric Pain Scale.;Nausea and vomiting. Timepoint: Before intervention, 7 and 10 days after intervention. Method of measurement: Rhodes inventory (Index of Nausea, Vomiting and Retching). | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences